It refers to a method of repeated gastrointestinal tract Clostridium infection in an experimental subject who has been pretreated more than once. This method includes pharmacological synthesis of an experimental subject, which contains a compound of formula (I) and butadiene. The pharmacological component consists of at least 93% of the formulated compound (I), which is administered in the form of a plate, capsule or suspensionSE REFIERE A UN METODO PARA TRATAR UNA INFECCION GASTROINTESTINAL RECURRENTE DE CLOSTRIDIUM DIFFICILE EN UN SUJETO QUE HA SIDO SOMETIDO A MAS DE UN TRATAMIENTO PREVIO, DICHO METODO COMPRENDE ADMINISTRAR A UN SUJETO UNA COMPOSICION FARMACEUTICA QUE CONTIENE UN COMPUESTO DE FORMULA (I) E HIDROXITOLUENO BUTILADO. LA COMPOSICION FARMACEUTICA COMPRENDE AL MENOS 93% DEL COMPUESTO DE FORMULA (I), LA CUAL SE ADMINISTRA EN FORMA DE UNA TABLETA, CAPSULA O SUSPENSION
